Free Trial
LON:CRW

Craneware (CRW) Share Price, News & Analysis

Craneware logo
GBX 1,995
+15.00 (+0.76%)
(As of 11/1/2024 ET)

About Craneware Stock (LON:CRW)

Key Stats

Today's Range
1,950
2,040
50-Day Range
1,700
2,340
52-Week Range
1,570
2,509.20
Volume
55,078 shs
Average Volume
84,325 shs
Market Capitalization
£705.03 million
P/E Ratio
7,673.08
Dividend Yield
1.45%
Price Target
GBX 2,700
Consensus Rating
Buy

Company Overview

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Craneware Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
46th Percentile Overall Score

CRW MarketRank™: 

Craneware scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Craneware has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Craneware has only been the subject of 1 research reports in the past 90 days.

  • Read more about Craneware's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Craneware is 7,673.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 128.25.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Craneware is 7,673.08, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 115.56.

  • Price to Book Value per Share Ratio

    Craneware has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CRW.
  • Dividend Yield

    Craneware pays a meaningful dividend of 1.56%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Craneware does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Craneware is 11,153.85%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Craneware's dividend.
  • Short Interest

    There is no current short interest data available for CRW.
  • News Sentiment

    Craneware has a news sentiment score of -0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Craneware this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for CRW on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Craneware insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £9,322,500 in company stock.

  • Percentage Held by Insiders

    19.28% of the stock of Craneware is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    60.17% of the stock of Craneware is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Craneware's insider trading history.
Receive CRW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Craneware and its competitors with MarketBeat's FREE daily newsletter.

CRW Stock News Headlines

Crypto Crash Ahead? (27 Experts Weigh In)
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
Craneware And 2 Other High Growth Tech Stocks In The UK
High Growth Tech Stocks To Watch In The UK October 2024
Top UK Growth Companies With High Insider Ownership
See More Headlines

CRW Stock Analysis - Frequently Asked Questions

Craneware's stock was trading at GBX 1,750 at the start of the year. Since then, CRW shares have increased by 14.0% and is now trading at GBX 1,995.
View the best growth stocks for 2024 here
.

Shares of CRW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Craneware investors own include Rolls-Royce Holdings plc (RR.L), accesso Technology Group (ACSO), Greencore Group (GNC), Nikola (NKLA), ASOS (ASC), Babcock International Group (BAB) and ChargePoint (CHPT).

Company Calendar

Today
11/02/2024
Ex-Dividend for 12/18 Dividend
11/28/2024
Dividend Payable
12/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
734
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 2,700
High Stock Price Target
GBX 2,700
Low Stock Price Target
GBX 2,700
Potential Upside/Downside
+35.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£11.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£189.27 million
Cash Flow
GBX 135.56 per share
Book Value
GBX 941 per share

Miscellaneous

Free Float
N/A
Market Cap
£705.03 million
Optionable
Not Optionable
Beta
0.28
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (LON:CRW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners